Intera Atlas
Run match
Sites / Elite Research Network
Is this you?

Request access for Elite Research Network with your @eliteresearchnetwork.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Elite Research Network

Unclaimed profile

Site Network · Mount Pleasant, South Carolina (network-based) · ~50+ independent sites (updated to 50+ from original 30+; 400+ studies/year) sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 7Lift (cardio sample) 0.24Recruit soph 0.14
Quality Scorecard (1–100)
Overall61Recruit50Ops74Sponsor60Ther59

Performance (observed)

Historical trials
141
Completed
97
Terminated/Withdrawn
14
Completion rate
87%
Active now
29
Phase 2
37
Phase 3
97
Realized enrollment
241,207
First study year
2002
Years active
24
Match confidence
low
Enrollment velocity (inf)
10,050

Therapeutic

Areas
Broad range across multiple therapeutic areas
Specialties
Multi-therapeutic (all phases): diverse therapeutic areas
Breadth (conditions)
106
Languages
English + Spanish (detected)
States
Nationwide (US)

Recruitment (web observed)

Advertises recruitment
Yes
Capability notes
Strong enrollment focus; predictive analytics for site/investigator selection; central IRB; rapid regulatory document turnaround (≤5 days); meets/exceeds enrollment targets consistently

Relationships

Sponsors
Pfizer; Eli Lilly and Company; Novo Nordisk A/S; Shire; Amgen; Mineralys Therapeutics Inc.
CROs
Parexel; Worldwide Clinical Trials
Partnerships
SCRS Global Impact Partner (2024)
Owner / parent
Founder-led; independent
Funding
Unfunded/Self-sustained; revenue ~$9M
Expansion
Y (50+ sites, ongoing growth)

Capacity & people

Investigators
—
Coordinators
—
CEO
Chris Hoyle, MBA (Founder & Executive Director, founded 2004)

Tech & DCT

CTMS
Unknown (uses CTMS for analytics)
EHR
Unknown (uses EMR data)
eSource
Yes
Uses AI
Yes
Builds tech
Vendors (uses standard CTMS and analytics tools)
Home visits
N
DCT / decentralized
N
Tech stack
Standard CTMS, EMR data integration, predictive analytics
Recruiting visible
Y (400+ studies/year)

Notes

Multi-site founder-led network with 50+ sites; strong recruitment focus; consistent enrollment performance; uses predictive analytics for site selection; broad therapeutic mix; well-established (founded 2004); SCRS Global Impact Partner; good fit for Intera as recruitment-focused, founder-led, innovative analytics approach [Validated: 3 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.28Liftability 0.24Overall61

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.